Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Hisataka Yasuda1, Nobuyuki Shima1, N. Nakagawa1, Kyoji Yamaguchi1, Masahiko Kinosaki1, Shin-ichi Mochizuki1, Akihiro Tomoyasu1, Kazuki Yano1, Masaaki Goto1, Akihiko Murakami1, Toshio Suda1, Tomonori Morinaga1, Kanji Higashio1, Nobuyuki Udagawa1, Naoyuki Takahashi1, Tatsuo Suda1
1Research Institute of Life Science, Snow Brand Milk Products Co., Ltd., 519 Ishibashi-machi, Shimotsuga-gun, Tochigi 329-0512, Japan; and Department of Biochemistry, School of Dentistry, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan

Tóm tắt

Osteoclasts, the multinucleated cells that resorb bone, develop from hematopoietic cells of monocyte/macrophage lineage. Osteoclast-like cells (OCLs) are formed by coculturing spleen cells with osteoblasts or bone marrow stromal cells in the presence of bone-resorbing factors. The cell-to-cell interaction between osteoblasts/stromal cells and osteoclast progenitors is essential for OCL formation. Recently, we purified and molecularly cloned osteoclastogenesis-inhibitory factor (OCIF), which was identical to osteoprotegerin (OPG). OPG/OCIF is a secreted member of the tumor necrosis factor receptor family and inhibits osteoclastogenesis by interrupting the cell-to-cell interaction. Here we report the expression cloning of a ligand for OPG/OCIF from a complementary DNA library of mouse stromal cells. The protein was found to be a member of the membrane-associated tumor necrosis factor ligand family and induced OCL formation from osteoclast progenitors. A genetically engineered soluble form containing the extracellular domain of the protein induced OCL formation from spleen cells in the absence of osteoblasts/stromal cells. OPG/OCIF abolished the OCL formation induced by the protein. Expression of its gene in osteoblasts/stromal cells was up-regulated by bone-resorbing factors. We conclude that the membrane-bound protein is osteoclast differentiation factor (ODF), a long-sought ligand mediating an essential signal to osteoclast progenitors for their differentiation into osteoclasts. ODF was found to be identical to TRANCE/RANKL, which enhances T-cell growth and dendritic-cell function. ODF seems to be an important regulator in not only osteoclastogenesis but also immune system.

Từ khóa


Tài liệu tham khảo

T Suda, N Takahashi, T J Martin Endocr Rev 13, 66–80 (1992).

T Suda, N Takahashi, T J Martin Endocrine Review Monographs, eds D D Bikle, A Negrovilar (Endocrine Soc., Bethesda) 4, 266–270 (1995).

T Suda, N Udagawa, I Nakamura, C Miyaura, N Takahashi Bone 17, 87S–91S (1995).

G D Roodman Endocr Rev 17, 308–332 (1996).

N Takahashi, T Akatsu, N Uadagawa, T Sasaki, A Yamaguchi, J M Moseley, T J Martin, T Suda Endocrinology 123, 2600–2602 (1988).

N Udagawa, N Takahashi, T Akatsu, T Sasaki, A Yamaguchi, H Kodama, T J Martin, T Suda Endocrinology 125, 1805–1813 (1989).

T Yamashita, K Asano, N Takahashi, T Akatsu, N Udagawa, T Sasaki, T J Martin, T Suda J Cell Physiol 145, 587–595 (1990).

E Tsuda, M Goto, S Mochizuki, K Yano, F Kobayashi, T Morinaga, K Higashio Biochem Biophys Res Commun 234, 137–142 (1997).

H Yasuda, N Shima, N Nakagawa, S Mochizuki, K Yano, N Fujise, Y Sato, M Goto, K Yamaguchi, M Kuriyama, T Kanno, A Murakami, E Tsuda, T Morinaga, K Higashio Endocrinology 139, 1329–1337 (1998).

W S Simonet, D L Lacey, C R Dunstan, M Kelley, M-S Chang, et al. Cell 89, 309–319 (1997).

Y Takebe, M Seiki, J Fujisawa, P Hoy, K Yokota, K Arai, M Yoshida, N Arai Mol Cell Biol 8, 466–472 (1988).

, eds F M Ausubel, R Brent, R E Kingston, D D Moore, J G Seidman, J A Smith, K Struhl (Wiley, New York Current Protocols in Molecular Biology, 1997).

T Tamura, N Takahashi, T Akatsu, T Sasaki, N Udagawa, S Tanaka, T Suda J Bone Miner Res 8, 953–960 (1993).

A E Bolton, W M Hunter Biochem J 133, 529–539 (1973).

H Yasuda, E Imai, A Shiota, N Fujise, T Morinaga, K Higashio Hepatology 24, 636–642 (1996).

T Akatsu, T Tamura, N Takahashi, N Udagawa, S Tanaka, T Sasaki, A Yamaguchi, N Nagata, T Suda J Bone Miner Res 7, 1297–1306 (1992).

B Beutler, C van Huffel Science 264, 667–668 (1994).

C A Smith, T Farrah, R G Goodwin Cell 76, 959–962 (1994).

H-J Gruss, S K Dower Blood 85, 3378–3404 (1995).

B R Wong, J Rho, J Arron, E Robinson, J Orlinick, M Chao, S Kalachikov, E Cayani, F S Bartlett, W N Frankel, S Y Lee, Y Choi J Biol Chem 272, 25190–25194 (1997).

D A Anderson, E Maraskovsky, W L Billingsley, W C Dougall, M E Tometsko, E R Roux, M C Teepe, R F DuBose, D Cosman, L Galibert Nature (London) 390, 175–179 (1997).

T J Chambers, T J Hall Vitamins Hormones 46, 41–86 (1991).

N Udagawa, N Takahashi, T Akatsu, H Tanaka, T Sasaki, T Nishihara, T Koga, T J Martin, T Suda Proc Natl Acad Sci USA 87, 7260–7264 (1990).

T J Chambers, J M Owens, G Hattersley, P S Jat, M D Noble Proc Natl Acad Sci USA 90, 5578–5582 (1993).

J H Shin, A Kukita, O Kazunori, T Katsuki, O Kohashi Endocrinology 136, 4285–4292 (1995).

A Miyamoto, T Kunisada, H Hemmi, T Yamane, H Yasuda, K Miyake, H Yamazaki, S-I Hayashi Biochem Biophys Res Commun 242, 703–709 (1998).

H Yoshida, S Hayashi, T Kunisada, M Ogawa, S Nishikawa, H Okamura, T Sudo, L D Shultz, S Nishikawa Nature (London) 345, 442–444 (1990).

N Takahashi, N Uadagawa, T Akatsu, H Tanaka, Y Isogai, T Suda Endocrinology 128, 1792–1796 (1991).

G Hattersley, J Owens, A M Flanagan, T J Chambers Biochem Biophys Res Commun 177, 526–531 (1991).

H Kodama, M Nose, S Niida, A Yamasaki J Exp Med 173, 1291–1294 (1991).

S Tanaka, N Takahashi, N Udagawa, T Tamura, T Akatsu, E R Stanley, T Kurokawa, T Suda J Clin Invest 91, 257–263 (1993).

S L Perkins, S J Kling Am J Physiol 269, E1024–E1030 (1995).

K S Akagawa, N Takasuka, Y Nozaki, I Komuro, M Azuma, M Ueda, M Naito, K Takahashi Blood 88, 4029–4039 (1996).

V Iotsova, J Caamano, J Loy, Y Yang, A Lewin, R Bravo Nature Med 3, 1285–1289 (1997).

J Lemire Vitamin D, eds D Feldman, F H Glorieux, J W Pike (Academic, San Diego), pp. 1167–1181 (1997).